Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulio Rossi

Showing results (271-280 of 341) with videos related to

Pageof 35
Sort By:
Endocrine Pathology|January 7, 2021
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine NeoplasmsChiara Liverani, Alberto Bongiovanni, Laura Mercatali, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2016
In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed dosesMauro Carrara, Chiara Tenconi, Giulio Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2009
Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markersMarcello Tiseo, Giulio Rossi, Marzia Capelletti, et al.
Plos One|August 1, 2012
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implicationsAntonio Marchetti, Maela Del Grammastro, Giampaolo Filice, et al.
The American Journal of Surgical Pathology|November 6, 2019
Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous CarcinomasFederica Zito Marino, Giulio Rossi, Marco Montella, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance schemeAntonio Marchetti, Massimo Barberis, Mauro Papotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lungGiulio Rossi, Alberto Cavazza, Alessandro Marchioni, et al.
Virchows Archiv : an International Journal of Pathology|September 29, 2023
Clinical impact of mixed pulmonary carcinoma and carcinoid: the driver from their mono-clonal originPaolo Graziano, Paola Parente, Flavia Centra, et al.
Virchows Archiv : an International Journal of Pathology|August 19, 2016
Testing for ROS1 in non-small cell lung cancer: a review with recommendationsLukas Bubendorf, Reinhard Büttner, Fouad Al-Dayel, et al.
Respiration; International Review of Thoracic Diseases|April 28, 2022
Accuracy and Predictors of Success of EUS-B-FNA in the Diagnosis of Pulmonary Malignant Lesions: A Prospective Multicenter Italian StudyMichele Mondoni, Stefano Gasparini, Francesco Varone, et al.
Pageof 35

Showing results (271-280 of 341) with videos related to

Sort By:
Pageof 35
Endocrine Pathology|January 7, 2021
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine NeoplasmsChiara Liverani, Alberto Bongiovanni, Laura Mercatali, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 23, 2016
In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed dosesMauro Carrara, Chiara Tenconi, Giulio Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2009
Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markersMarcello Tiseo, Giulio Rossi, Marzia Capelletti, et al.
Plos One|August 1, 2012
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implicationsAntonio Marchetti, Maela Del Grammastro, Giampaolo Filice, et al.
The American Journal of Surgical Pathology|November 6, 2019
Heterogeneity of PD-L1 Expression in Lung Mixed Adenocarcinomas and Adenosquamous CarcinomasFederica Zito Marino, Giulio Rossi, Marco Montella, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2014
ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance schemeAntonio Marchetti, Massimo Barberis, Mauro Papotti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lungGiulio Rossi, Alberto Cavazza, Alessandro Marchioni, et al.
Virchows Archiv : an International Journal of Pathology|September 29, 2023
Clinical impact of mixed pulmonary carcinoma and carcinoid: the driver from their mono-clonal originPaolo Graziano, Paola Parente, Flavia Centra, et al.
Virchows Archiv : an International Journal of Pathology|August 19, 2016
Testing for ROS1 in non-small cell lung cancer: a review with recommendationsLukas Bubendorf, Reinhard Büttner, Fouad Al-Dayel, et al.
Respiration; International Review of Thoracic Diseases|April 28, 2022
Accuracy and Predictors of Success of EUS-B-FNA in the Diagnosis of Pulmonary Malignant Lesions: A Prospective Multicenter Italian StudyMichele Mondoni, Stefano Gasparini, Francesco Varone, et al.
Pageof 35